The first and most widely used therapeutic macrophage-based strategy has been TAM depletion from tumor sites via the inhibition of colony stimulating factor-1/colony stimulating factor-1 receptor (CSF-1/CSF-1R) and CCL2/CCR2 inhibition [100,101]. Here, CSF1R is linked to neoplasm.